Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)

Trial Profile

Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer. A Multicenter Phase Ib Trial (RECAP)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2017

At a glance

  • Drugs Regorafenib (Primary) ; Capecitabine
  • Indications Rectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RECAP
  • Most Recent Events

    • 07 Nov 2017 Planned number of patients changed from 37 to 24.
    • 24 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 29 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top